AAPM Recommends Against Use of Bismuth Shielding for CT Scanning
In a position statement, the American Association of Physicists in Medicine advise against using bismuth shields for dose reduction in CT scanning when alternatives are available.
Regular use of bismuth shields during CT scanning to protect anterior organs is not recommended by the American Association of Physicists in Medicine (AAPM) when alternatives for shielding are available.
Bismuth shielding has been traditionally used to shield radiosensitive organs such as the breast, lens of the eye and thyroid during CT scans.
“However, bismuth shielding degrades image quality, attenuates photons exiting the patient, and causes unpredictable results when combined with automatic exposure control systems,” the group said in a position statement released this week. Click here for a pdf of the full statement.
According to the AAPM, there are several known disadvantages to bismuth shield use, such as degrading image quality and accuracy, unpredictable and potentially undesirable levels of dose and image quality, and waste of some of the patient’s radiation exposure.
To avoid the use of the shield, suggestions include reducing the dose to the specific peripheral organs by adjusting automatic exposure controls (AEC) parameters and using organ-based tube current modulation techniques.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
